Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shing Fen Kao

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Blood Cells, Molecules & Diseases|July 10, 2003
Autologous immunotherapy for human leukemiasDavid Claxton, Shing Fen Kao
Journal of Immunological Methods|September 6, 2016
A simple tube adapter to expedite and automate thawing of viably frozen cellsMargaret Beddall, Pratip K Chattopadhyay, Shing-Fen Kao, et al.
Journal of Immunological Methods|September 8, 2012
Optimization and qualification of an 8-color intracellular cytokine staining assay for quantifying T cell responses in rhesus macaques for pre-clinical vaccine studiesMitzi M Donaldson, Shing-Fen Kao, Leila Eslamizar, et al.
Vaccine|October 9, 2013
Safety and tolerability of a live oral Salmonella typhimurium vaccine candidate in SIV-infected nonhuman primatesAlida Ault, Sharon M Tennant, J Patrick Gorres, et al.
Journal of Virology|February 17, 2017
Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell ResponsesGerard Zurawski, Xiaoying Shen, Sandra Zurawski, et al.
Journal of Virology|June 5, 2015
Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman PrimatesJuan García-Arriaza, Beatriz Perdiguero, Jonathan Heeney, et al.
Plos One|April 15, 2016
Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus MacaquesGerard Zurawski, Sandra Zurawski, Anne-Laure Flamar, et al.
Journal of Virology|November 16, 2018
Priming with a Potent HIV-1 DNA Vaccine Frames the Quality of Immune Responses prior to a Poxvirus and Protein BoostBenedikt Asbach, Karen V Kibler, Josef Köstler, et al.
Cell Reports|January 5, 2022
Potent anti-viral activity of a trispecific HIV neutralizing antibody in SHIV-infected monkeysAmarendra Pegu, Ling Xu, Megan E DeMouth, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Blood Cells, Molecules & Diseases|July 10, 2003
Autologous immunotherapy for human leukemiasDavid Claxton, Shing Fen Kao
Journal of Immunological Methods|September 6, 2016
A simple tube adapter to expedite and automate thawing of viably frozen cellsMargaret Beddall, Pratip K Chattopadhyay, Shing-Fen Kao, et al.
Journal of Immunological Methods|September 8, 2012
Optimization and qualification of an 8-color intracellular cytokine staining assay for quantifying T cell responses in rhesus macaques for pre-clinical vaccine studiesMitzi M Donaldson, Shing-Fen Kao, Leila Eslamizar, et al.
Vaccine|October 9, 2013
Safety and tolerability of a live oral Salmonella typhimurium vaccine candidate in SIV-infected nonhuman primatesAlida Ault, Sharon M Tennant, J Patrick Gorres, et al.
Journal of Virology|February 17, 2017
Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell ResponsesGerard Zurawski, Xiaoying Shen, Sandra Zurawski, et al.
Journal of Virology|June 5, 2015
Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman PrimatesJuan García-Arriaza, Beatriz Perdiguero, Jonathan Heeney, et al.
Plos One|April 15, 2016
Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus MacaquesGerard Zurawski, Sandra Zurawski, Anne-Laure Flamar, et al.
Journal of Virology|November 16, 2018
Priming with a Potent HIV-1 DNA Vaccine Frames the Quality of Immune Responses prior to a Poxvirus and Protein BoostBenedikt Asbach, Karen V Kibler, Josef Köstler, et al.
Cell Reports|January 5, 2022
Potent anti-viral activity of a trispecific HIV neutralizing antibody in SHIV-infected monkeysAmarendra Pegu, Ling Xu, Megan E DeMouth, et al.
Pageof 1